Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition: Gastroesophageal Reflux DiseaseInterventions: Drug: Dexlansoprazole 30 mg; Drug: Dexlansoprazole 60 mgSponsor: TakedaNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition: Gastroesophageal Reflux DiseaseInterventions: Drug: Dexlansoprazole 30 mg; Drug: Dexlansoprazole 60 mgSponsor: TakedaRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition: Gastroesophageal Reflux DiseaseInterventions: Drug: Dexlansoprazole 30 mg; Drug: Dexlansoprazole 60 mgSponsor: TakedaNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials
Dexlansoprazole MR in Nonerosive Reflux Disease
Condition: Nonerosive Reflux DiseaseIntervention: Drug: Dexlansoprazole MRSponsor: Soonchunhyang University HospitalEnrolling by invitation - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2014 Category: Research Source Type: clinical trials